Shandong Lukang Pharmaceutical Co., Ltd. is a large-scale state-owned bio-pharmaceutical enterprise established in 1966 that specialises in the research and development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms (FDF) for human, veterinary, and agricultural use. The company is committed to developing high-quality products, with notable offerings including Spectinomycin HCl/Sulfate, Tylosin Tartrate, and Flunixin Meglumine, all of which are approved by international regulatory bodies such as the CEP and FDA.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Research and Development
- Manufacturing
- Marketing of finished dosage forms
- Veterinary pharmaceutical products
- Agricultural pharmaceutical products

Shandong Lukang Pharmaceutical Co., Ltd. continues to be a key supplier in the pharmaceutical industry, offering a diverse range of products tailored to meet various market needs. For more information, please visit lkpc.com.